-
they will focus on developing microneedle skin patches to deliver next generation malaria vaccines based on newly identified antigens and newly licensed adjuvants. The research will involve designing, testing
-
Cork. The scientist will work within a Horizon-Europe-funded consortium, OptiViVax, where they will focus on developing microneedle skin patches to deliver next generation malaria vaccines based on newly
-
that disproportionately affect those in developing countries, such as malaria and other tropical diseases. These tools will be made freely accessible via an open-source, web-based platform, ensuring
-
-funded consortium, OptiViVax, where they will focus on developing microneedle skin patches to deliver next generation malaria vaccines based on newly identified antigens and newly licensed adjuvants